StayCurrentMD · Development of a novel tubular scaffold for tissue-engineered small intestine
Article1 min read·Published Aug 2025

Development of a novel tubular scaffold for tissue-engineered small intestine

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Aug 2025 · 1 min read

In brief

In brief

Researchers developed a tubular scaffold designed to align smooth muscle cells and restore peristaltic function in tissue-engineered small intestine. This innovation addresses a critical challenge for infants with short bowel syndrome who depend on parenteral nutrition and face high morbidity.

  • Short bowel syndrome in infants carries high morbidity/mortality, particularly with parenteral nutrition dependence.
  • Tissue-engineered small intestine (TESI) is a potential therapeutic option but achieving normal peristalsis remains challenging.
  • Novel tubular scaffolds can promote smooth muscle cell alignment to improve peristaltic function in TESI constructs.

Written by the GCMD Library team from the article.

Infants with short bowel syndrome (SBS) have significant morbidity and mortality, especially if they depend on parenteral nutrition. Tissue-engineered small intestine (TESI) has been considered a potential therapeutic option for SBS but normal peristaltic function remains a challenge. The purpose of this study was to develop a novel tubular scaffold that promotes smooth muscle cell (SMC) alignment and ultimately peristalsis of TESI constructs.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →